Laurus Investment Counsel’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,690
Closed -$640K 45
2024
Q3
$640K Hold
20,690
0.25% 36
2024
Q2
$650K Hold
20,690
0.27% 34
2024
Q1
$1.11M Hold
20,690
0.39% 35
2023
Q4
$1.08M Sell
20,690
-1,660
-7% -$69.5K 0.39% 33
2023
Q3
$1.34M Hold
22,350
0.56% 29
2023
Q2
$1.29M Hold
22,350
0.46% 33
2023
Q1
$1.32M Buy
+22,350
New +$987K 0.47% 35

Other funds holding NRC

Laurus Investment Counsel's NRC Position: Q4 2024 in Review

Laurus Investment Counsel sold out of NRC Health Common Stock (NRC) in Q4 2024, closing a stake of 20,690 shares — an estimated $640K sold.

Laurus Investment Counsel first reported a position in NRC in Q1 2023 and held it in 7 quarters. The position peaked at $1.34M in Q3 2023. 133 funds tracked by Wall St. Rank hold NRC as of Q4 2024.

  • Laurus Investment Counsel reported no remaining NRC Health Common Stock position as of Q4 2024 after selling out during the quarter.
  • Laurus Investment Counsel sold 20,690 NRC Health Common Stock shares in Q4 2024, an estimated $640K.
  • Laurus Investment Counsel first reported a position in NRC Health Common Stock in Q1 2023 and held it in 7 quarters.
  • Laurus Investment Counsel's NRC Health Common Stock position peaked at $1.34M in Q3 2023.
  • 133 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2024.

Based on Laurus Investment Counsel's 13F filing for Q4 2024, filed 24 Jan 2025.